|
2008 Conference Publication Hepcidin regulation in wild-type and HFE-/mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic responseFletcher, L. M., Heritage, M. L., Murphy, T. L., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2008). Hepcidin regulation in wild-type and HFE-/mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Copenhagen, Denmark: Elsevier. doi: 10.1016/S0168-8278(08)60888-0 |
|
2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, D. H. G., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W. and Ramm, G. A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. AGW 2008: Australian Gastroenterology Week 08, Brisbane, QLD, Australia, 22-25 October 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. doi: 10.1111/j.1440-1746.2008.05613.x |
|
2008 Conference Publication Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosisCrawford, Darrell H., Murphy, Therese L., Ramm, Louise E., Fletcher, Linda M., Clouston, Andrew D., Anderson, Gregory J., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2008). Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, U.S.A., 31 October-4 November 2008. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.22641 |
|
2008 Conference Publication Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver diseaseHickman, I. J., Sullivan, C. M., Flight, S., Campbell, C., Crawford, D. H., Masci, P. P., O'Moore-Sullivan, T. M., Prins, J. B. and Macdonald, G. A. (2008). Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease. 16th European Congress on Obesity, Geneva, Switzerland, 14-17 May 2008. LONDON: NATURE PUBLISHING GROUP. |
|
2008 Conference Publication Multiple pathways to hepatic fibrosis are inhibited by rapamycinBridle, K. R., Sobbe, A. L., Fletcher, L. M., Clouston, A. D. and Crawford, D. H. G. (2008). Multiple pathways to hepatic fibrosis are inhibited by rapamycin. Australian Gastroenterology Week 2008, Brisbane, Qld, Australia, 22-25 October 2008. Carlton South, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x |
|
2008 Conference Publication Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levelsPopa, C., Bridle, K. R., Morgan, M. L., Clouston, A. D., Fletcher, L. M. and Crawford, D. H. G. (2008). Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Ireland: Elsevier. doi: 10.1016/S0168-8278(08)60467-5 |
|
2008 Conference Publication Serum ferritin concentration predicts mortality and adverse liver-related clinical events in patients with cirrhosis listed for liver transplantationCrawford, D. H., Walkerl, N. M., Stuart, K. A., Fletcher, L. M., Ryon, R. J. and Nicol, J. (2008). Serum ferritin concentration predicts mortality and adverse liver-related clinical events in patients with cirrhosis listed for liver transplantation. 59th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 31 October-4 November 2008. HOBOKEN: WILEY-BLACKWELL PUBLISHING, INC. |
|
2007 Conference Publication Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosisHeritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J., Crawford, D. H. G. and Fletcher, L. M. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. Australian Gastroenterology Week 2007, Perth, Australia, 24–27 October 2007. Melbourne, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2007.05161.x |
|
2007 Conference Publication Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumptionFletcher, L. M., Heritage, M. L., Murphy, T. L., Bridle, K. R., Anderson, G. J. and Crawford, D. H. G. (2007). Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption. 2007 International BioIron Society Meeting, Kyoto, Japan, 1-6 April, 2007. New York: Wiley-LISS. doi: 10.1002/ajh.20964 |
|
2007 Conference Publication Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosisFletcher, L. M., Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, U.S.A., 1-6 November 2007. U.S.A.: Wiley InterScience. doi: 10.1002/hep.22022 |
|
2007 Conference Publication Rapamycin as an anti-fibrotic agentPopa, C., Bridle, K. R., Morgan, M. L., Robinson, M. W., Fletcher, L. M. and Crawford, D. H. (2007). Rapamycin as an anti-fibrotic agent. Australian Gastroenterology Week, Perth, Australia, 24-27 October 2007. Australia. doi: 10.1111/j.1440-1746.2007.05161.x |
|
2007 Conference Publication Does iron play a role in the pathogenesis and phenotype of hepatocellular carcinoma in patients with cirrhosis?Ryan, R., Fletcher, L., Jones, D., Stuart, K. and Crawford, D. (2007). Does iron play a role in the pathogenesis and phenotype of hepatocellular carcinoma in patients with cirrhosis?. 2007 International BioIron Society Meeting, Kyoto, Japan, 1-6 April 2007. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/ajh.20964 |
|
2006 Conference Publication Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agentMorgan, M. L., Bridle, K. R., Fletcher, L. M. and Crawford, D. H. G. (2006). Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent. Australian Gastroenterology Week, Adelaide, SA, Australia, 11-14 October 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
|
2006 Conference Publication Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesisBridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week, Adelaide, Australia, 11–14 October 2006. Oxford United Kingdom: Wiley. |
|
2006 Conference Publication Very low dose rapamycin: in vitro evidence for its use as an antifibrotic agentMorgan, M. L., Bridle, K. R., Fletcher, L. M. and Crawford, D. H. G. (2006). Very low dose rapamycin: in vitro evidence for its use as an antifibrotic agent. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
|
2006 Conference Publication Serum adiponectin is increased in HFE-/- mice fed alcoholBridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
|
2006 Conference Publication Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesisBridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
|
2006 Conference Publication Post liver transplantation disease recurrence: influence of matrix degradation proteinsBridle, K. R., Murphy, T. L., Fletcher, L. M. and Crawford, D. H. G. (2006). Post liver transplantation disease recurrence: influence of matrix degradation proteins. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x |
|
2005 Conference Publication Rapamycin, but not cyclosporine A or tacrolimus, reduces hepatic stellate cell activation: implications for post-transplant fibrogenesisBridle, K. R., Robinson, M. W., Fletcher, L. M. and Crawford, D. H. (2005). Rapamycin, but not cyclosporine A or tacrolimus, reduces hepatic stellate cell activation: implications for post-transplant fibrogenesis. Australian Gastroenterology Week 2005, Brisbane, Qld, Australia, 19-22 October, 2005. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2005.04091_4.x |
|
2005 Conference Publication Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.Powell, LW, Dixon, JL, Anderson, GA, Subramaniam, VN, Lincoln, DJ, Fletcher, LM, Crawford, DH, Searle, JW and Ramm, GA (2005). Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco CA, NOV 11-15, 2005. HOBOKEN: JOHN WILEY & SONS INC. |
